Amiodarone Infusion Protocol
The recommended protocol for amiodarone infusion is 150 mg administered over 10 minutes as an initial loading dose, followed by 1 mg/min for 6 hours (360 mg), and then 0.5 mg/min for 18 hours (540 mg), with a total dose of approximately 1000 mg over the first 24 hours. 1, 2
Initial Loading and Maintenance Dosing
First 24 Hours
- Loading dose: 150 mg IV over 10 minutes (can be repeated if necessary)
- Early maintenance: 1 mg/min for 6 hours (360 mg)
- Later maintenance: 0.5 mg/min for 18 hours (540 mg)
- Total first 24-hour dose: Approximately 1000 mg
After First 24 Hours
- Maintenance infusion: 0.5 mg/min (720 mg per 24 hours)
- This maintenance infusion can be continued for 2-3 weeks if needed
Administration Guidelines
Infusion Preparation
- Use a concentration of 1-6 mg/mL
- For infusions longer than 1 hour, do not exceed 2 mg/mL unless using a central venous catheter 2
- Administer using a volumetric infusion pump (not drop counter sets, which may lead to underdosing) 2
Administration Route
- Preferably administer through a central venous catheter, especially for concentrations >2 mg/mL 2
- Use an in-line filter during administration 2
- For peripheral administration, use concentrations ≤2.5 mg/mL to minimize phlebitis 2
Solution Compatibility
- Prepare in D5W (5% dextrose in water)
- For infusions exceeding 2 hours, use glass or polyolefin bottles containing D5W 2
- Do not use evacuated glass containers for admixing due to potential precipitation 2
Monitoring During Infusion
Cardiovascular Monitoring
- Continuous ECG monitoring during infusion
- Regular blood pressure monitoring (hypotension occurs in up to 16% of patients) 3
- Monitor for bradycardia and QT prolongation
Breakthrough Arrhythmias
- For breakthrough episodes of ventricular fibrillation or hemodynamically unstable ventricular tachycardia, administer supplemental 150 mg infusions of amiodarone (mixed in 100 mL of D5W and infused over 10 minutes) 2
Important Precautions
Dosing Limitations
- Do not exceed an initial infusion rate of 30 mg/min 2
- Mean daily doses above 2100 mg are associated with increased risk of hypotension 2
- Higher concentrations and faster infusion rates than recommended have resulted in hepatocellular necrosis and acute renal failure 2
Common Adverse Effects
- Hypotension (particularly during loading dose)
- Bradycardia
- Phlebitis (with peripheral administration)
- QT prolongation (rarely torsades de pointes)
Drug Interactions
- Amiodarone increases warfarin effect (reduce warfarin dose by 30-50%) 3
- Doubles serum digoxin levels (reduce digoxin dose) 3
- Increases risk of myopathy/rhabdomyolysis with statins 3
- Potentiates bradycardia with beta-blockers and calcium channel blockers 3
Clinical Pearls
- The hypotensive effect of IV amiodarone may persist throughout the maintenance infusion period, not just during the loading dose 4
- Amiodarone has an extremely long half-life (average 58 days), which impacts long-term management 3
- For patients transitioning to oral therapy, the typical oral loading dose is 600-800 mg daily for several weeks, followed by maintenance of 200-400 mg daily 3, 5
- Infusions of antiarrhythmic drugs should generally be discontinued after 6 to 24 hours, with reassessment of the need for further arrhythmia management 1